Ever Source Wealth Advisors, LLC Kymera Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 428 shares of KYMR stock, worth $20,398. This represents 0.0% of its overall portfolio holdings.
Number of Shares
428
Previous 26
1546.15%
Holding current value
$20,398
Previous $1,000
1000.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KYMR
# of Institutions
181Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$319 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$308 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$286 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$286 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$249 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.61B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...